Search

Glucommander

Print
glucommander_500x531
Glucommander from Glytec Systems

Glucommander™ is an FDA-cleared insulin management software that provides personalized insulin dosing recommendations and maximizing workflow efficiency for doctors and nurses. Glucommander helps providers manage patients across the continuum of care with support for intravenous, subcutaneous, and outpatient insulin management as well as the transitions between these stages

For complete information, Glytec Systems

Comprehensive Diabetes Management:
No
Journal: Glucose & Meal Tracking:
No
Nutrition analysis:
No
Fitness tracking:
No
Device Specific:
No
Medical Profile Storage:
No
Insulin dosing:
Yes
Education :
No
CGM Companion App:
No
Coaching:
Yes
For ADCESs & Healthcare:
Providers
Remote Patient Monitoring:
No
Data Management Platforms:
No
HIPAA Compliant Virtual Visit Platforms:
No
Insulin dosing in Hospital:
Yes

FDA & Regulatory:
Glucommander™ is FDA cleared (as a Class II medical device) for insulin dosing decision support.
Outcomes:

Glytec’s eGMS® is proven to:

  • Reduce Cost of Care
  • Reduce Readmissions
  • Reduce Length of Stay
  • Save Clinicians Time
  • Reduce Hypoglycemia
  • Reduce CABG Surgery Cost, Complications, and Resources
  • Successfully Convert from Sliding Scale to Basal Bolus Insulin
  • Reduce Point-of-Care Blood Glucose Tests
  • Reduce Admissions for Diabetic Ketoacidosis
  • Reduce Time to Target Blood Glucose
  • Reduce Outpatient A1C
Data Sharing:
Provides specific, personaized dosing recommendations directly to care givers and health care providers
Platforms & Modalitiy:
PC
Security & Privacy:
HIPAA Compliant
Cost & Payment:
No cost to consumer, hospital purchases software. Patient cannot use on their own.
More Details:
Glytec’s Glucommander™ is purpose built to overcome therapeutic inertia and drive the adoption of basal-bolus insulin therapy among providers by delivering evidence-based decision support at the point of care. Our proprietary algorithms do the heavy lifting, responding to each patient’s unique circumstances by computing when and by how much their insulin dose should be adjusted and creating personalized dosing recommendations for providers. Our technology has been implemented at nearly 300 hospitals and has been repeatedly proven to increase patient safety, decrease length of stay, reduce readmissions and drive down the overall cost of care. Glytec’s eGMS also enables detailed reporting of glycemic management metrics like incidence of hyperglycemia and hypoglycemia, time to target, patient utilization, blood glucose ranges and more.

Manufacturer Resources

    Contact

     

    The Danatech Digest

    Join 18,000+ professionals who get our latest diabetes technology updates

        

    DISCLAIMERS: 

    This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or healthcare provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit diabeteseducator.org.

    ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.

    Our Sponsors